Evidence map›Paper›PMID 38613857›Full record

Trial reportAddictive behaviors2024

Menthol versus tobacco e-liquid flavor: Impact on acute subjective effects, puff patterns, and intentions for use among Black and White menthol smokers.

Eleanor L S Leavens, Leah M Lambart, Gideon St Helen, Neal L Benowitz, Matthew S Mayo, Kazi M Farhad Mahmud, Michael J Arnold, Nicole L Nollen

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Addictive behaviors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eleanor L S LeavensUniversity of Kansas School of Medicine, Department of Population Health, Kansas City, KS, United States; The University of Kansas Cancer Center, Kansas City, KS, United States. Electronic address: eleavens@kumc.edu.
Leah M LambartUniversity of Kansas School of Medicine, Department of Population Health, Kansas City, KS, United States.
Gideon St HelenClinical Pharmacology Research Program, Division of Cardiology, University of California, San Francisco, CA, United States.
Neal L BenowitzClinical Pharmacology Research Program, Division of Cardiology, University of California, San Francisco, CA, United States.
Matthew S MayoThe University of Kansas Cancer Center, Kansas City, KS, United States; University of Kansas School of Medicine, Department of Biostatistics & Data Science, Kansas City, KS, United States.
Kazi M Farhad MahmudUniversity of Kansas School of Medicine, Department of Biostatistics & Data Science, Kansas City, KS, United States.
Michael J ArnoldUniversity of Kansas School of Medicine, Department of Population Health, Kansas City, KS, United States.
Nicole L NollenUniversity of Kansas School of Medicine, Department of Population Health, Kansas City, KS, United States; The University of Kansas Cancer Center, Kansas City, KS, United States.
University of Kansas · USUniversity of California, San Francisco · USThe University of Kansas Cancer Center · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPRINGER, MATTHEW LAWRENCE · 2018 to 2022
$20.4M
Clinical Pharmacology of Electronic CigarettesR01DA039264 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BENOWITZ, NEAL L · 2015 to 2021
$4.5M
NRSA Training CoreTL1TR002368 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jennifer Lynn Goldman, NICOLE L NOLLEN · 2017 to 2026
$4.0M
Impact of e-cigarette nicotine concentration on compensation, cigarette use, and biomarkers of exposure and harm in African American and White smokersK01DA054995 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LEAVENS, ELEANOR LADD SCHNEIDER · 2021 to 2025
$882k
NCATS NIH HHS TL1 TR002368NCI NIH HHS P30 CA168524NHLBI NIH HHS U54 HL147127NIDA NIH HHS K01 DA054995NIDA NIH HHS R01 DA039264
6 · The paper itself

Abstract

backgroundThe proposed FDA product standard to prohibit menthol as a characterizing flavor in combustible cigarettes has the potential to significantly reduce tobacco-related health disparities. Whether a menthol e-liquid product standard would improve or hinder public health is unknown. No known research has directly examined the impact of menthol vs. tobacco flavored e-liquid use on acute e-cigarette use patterns, subjective experience, behavioral intentions, and craving and withdrawal among menthol cigarette smokers.

methodsBlack (n = 47) and White (n = 4) nicotine-deprived menthol smokers with limited e-cigarette experience completed two counterbalanced in-laboratory 30-minute ad libitum vaping sessions with menthol and tobacco nicotine salt-based e-liquid in a randomized crossover pilot trial design. Questionnaires assessed reductions in craving and withdrawal and post-session subjective experience and behavioral intentions. Puff topography was measured continuously throughout each vaping session.

resultsMeasures of puff topography did not differ significantly by e-liquid flavor (all p > .40). Similarly, menthol and tobacco flavored e-cigarettes were both rated positively in terms of subjective effects and behavioral intentions (all p > .10) and about 40 % of participants reported a preference for the tobacco-flavored e-liquid. Finally, participants showed comparable reductions in craving (p = .210) and withdrawal (p = .671) from pre- and post-session regardless of e-liquid flavor.

conclusionsAmong menthol smokers in a lab-based setting, findings suggest that menthol vs tobacco e-liquid flavor has little impact on acute changes in puff patterns, subjective experience, behavioral intentions, or craving and withdrawal.

Indexed as

Black or African AmericanElectronic Nicotine Delivery SystemsFlavoring AgentsMentholSubstance Withdrawal SyndromeVapingWhite PeopleAdultCravingCross-Over StudiesFemaleHumansIntentionMaleMiddle AgedPilot ProjectsFlavoring AgentsMentholElectronic cigarettesFlavorMentholSmoking

Identifiers

PMID38613857
PMCPMC11221762
OpenAlexW4394795398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.